Clinical Trial Update: NNITS-Nitazoxanide for Norovirus in Transplant Patients Study [Phase 2]

View source ↗

Summary

Phase 2 trial results for NNITS-Nitazoxanide in norovirus gastroenteritis among transplant patients have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Norovirus Gastroenteritis

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Gastroenteritis Norovirus | Phase 2 | Status: COMPLETED | Results posted: 2022-10-24